Christine Armour

Investigator

Dr. Christine Armour, MS MD FRCPC CCMG, is an Associate Professor of Pediatrics at the University of Ottawa, Clinical Geneticist at CHEO, co-Medical Director (Genetics) of Prenatal Screening Ontario, and Investigator at CHEO Research Institute. Dr. Armour is a leading clinical expert in prenatal genetics who works with policy makers to improve prenatal and reproductive care. Her research program studies the application of innovative technologies in prenatal screening, prenatal diagnostics, and reproductive care. She also applies novel data science and machine learning approaches to population-based data to improve the performance of Ontario’s prenatal screening system and develop predictive models. Dr. Armour efficiently translates research findings into clinical practice: she is a Member of Ontario’s Provincial Genetics Advisory Committee, has led several Canadian guidelines on the clinical application of genetic technologies, helped establish Prenatal Screening Ontario, and co-developed provincial eligibility criteria for non-invasive prenatal testing and fetal exome sequencing.

 

Related News

Research Projects

  1. Transformer-based deep learning ensemble framework predicts autism spectrum disorder using health administrative and birth registry data.

    07/04/2025

    Early diagnosis and access to resources, support and therapy are critical for improving long-term outcomes for children with autism spectrum disorder (ASD). ASD is typically detected using a case-finding approach based on symptoms and family history, resulting in many delayed or missed diagnoses.

  2. Outcomes of pregnancies with varying levels of nuchal translucency measurements: A population-based retrospective study in Ontario, Canada

    29/09/2024

    This study aimed to investigate the association between nuchal translucency measurements and pregnancy outcome, specifically, a composite of pregnancy loss, termination, stillbirth, or neonatal death.

  3. Pregnancies with ‘double-positive’ multiple marker screening results: a population-based study in Ontario, Canada.

    06/09/2024